Altered endothelin receptor subtypes in colorectal cancer

European Journal of Gastroenterology and Hepatology

Volumn 19, Issue 9, 2007, Pages 775-782

  Hoosein, Moinuddin M ^a   Dashwood, Michael R ^a   Dawas, Khaled ^a   Ali, Haythem M M D A ^a   Grant, Katherine ^a   Savage, Felicity ^a   Taylor, Irving ^a   Loizidou, Marilena ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Colorectal cancer; Endothelin receptors; Endothelin 1

Indexed keywords

CD31 ANTIGEN; ENDOTHELIAL CELL ANTIBODY; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; RADIOLIGAND;

ARTICLE; AUTORADIOGRAPHY; BLOOD VESSEL; CANCER CELL; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NERVE FIBER; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; TISSUE SECTION;

COLON; COLORECTAL NEOPLASMS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FIBROBLASTS; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; UP-REGULATION;

EID: 34547962065     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282c563de     Document Type: Article

References (31)

1. Grant K, Loizidou M, Taylor I. Endothelin-1: a multifunctional molecule in cancer. Br J Cancer 2003; 88:163-166.
2. Shankar A, Loizidou M, Aliev G, Fredericks S, Holt D, Boulos PB, et al. Raised endothelin 1 levels in patients with colorectal liver metastases. Br J Surg 1998; 85:502-506.
3. Asham E, Shankar A, Loizidou M, Fredericks S, Miller K, Boulos PB, et al. Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ET(A) receptor antagonism. Br J Cancer 2001; 85:1759-1763.
4. Inagaki H, Bishop AE, Eimoto T, Polak JM. Autoradiographic localization of endothelin-1 binding sites in human colonic cancer tissue. J Pathol 1992; 168:263-267.
5. Egidy G, Juillerat-Jeanneret L, Jeannin JF, Korth P, Bosman FT, Pinet F. Modulation of human colon tumor-stromal interactions by the endothelin system. Am J Pathol 2000; 157:1863-1874.
6. Ali H, Dashwood M, Dawas K, Loizidou M, Savage F, Taylor I. Endothelin receptor expression in colorectal cancer. J Cardiovasc Pharmacol 2000; 36 (5 Suppl 1):S69-S71.
7. Nelson JB, Chan-Tack K, Hedican SP, Magnuson SR, Opgenorth TJ, Bova GS, Simons JW. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer Res 1996; 56:663-668.
8. Bagnato A, Salani D, Di CV, Wu-Wong JR, Tecce R, Nicotra MR, et al. Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth. Cancer Res 1999; 59:720-727.
9. Wulfing P, Diallo R, Kersting C, Wülfing C, Poremba C, Rody A et al. Expression of endothelin-1, endothelin-A, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up. Clin Cancer Res 2003; 9:4125-4131.
10. Bagnato A, Tecce R, Di CV, Catt KJ. Activation of mitogenic signaling by endothelin 1 in ovarian carcinoma cells. Cancer Res 1997; 57:1306-1311.
11. Grant K, Knowles J, Dawas K, Taylor I, Burnstock G, Loizidou M. Mitogenic mechanisms of endothelin-1 in colorectal cancer cells. Br J Surg 2007; 94:106-112.
12. Peduto EL, Bovey R, Juillerat-Jeanneret L. Endothelin-receptor antagonists are proapoptotic and antiproliferative in human colon cancer cells. Br J Cancer 2003; 88:788-795.
13. Moraitis S, Miller WR, Smyth JF, Langdon SP. Paracrine regulation of ovarian cancer by endothelin. Eur J Cancer 1999; 35:1381-1387.
14. Rosano L, Varmi M, Salani D, Di Castro V, Spinella F, Natali PG, Bagnato A. Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells. Cancer Res 2001; 61:8340-8346.
15. Spinella F, Rosano L, Di Castro V, Natali PG, Bagnato A. Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1α in ovarian carcinoma cells. J Biol Chem 2002; 277:27850-27855.
16. Dashwood MR, Timm M, Muddle JR, Ong ACM, Tippins JR, Parker RP, et al. Regional variations in endothelin-1 and its receptor subtypes in human coronary vasculature: pathophysiological implications in coronary disease. Endothelium 1998; 6:61-70.
17. Gohji K, Kitazawa S, Tamada H, Katsuoka Y, Nakajima M. Expression of endothelin receptor A associated with prostate cancer progression. J Urol 2001; 165:1033-1036.
18. Wulfing P, Tio J, Kersting C, Sonntag B, Buerger H, Wülfing C, et al. Expression of endothelin-A-receptor predicts unfavourable response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 2004; 91:434-440.
19. Jeronimo C, Henrique R, Campos PF, Oliveira J, Caballero OL, Lopes C, Sidransky D. Endothelin B receptor gene hypermethylation in prostate adenocarcinoma. J Clin Pathol 2003; 56:52-55.
20. Pao MM, Tsutsumi M, Liang G, Uzvolgyi E, Gonzales FA, Jones PA. The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells. Hum Mol Genet 2001; 10:903-910.
21. Alanen K, Deng DX, Chakrabarti S. Augmented expression of endothelin-1, endothelin-3 and the endothelin-B receptor in breast carcinoma. Histopathology 2000; 36:161-167.
22. Demunter A, Wolf-Peeters C, Degreef H, Stas M, van den Oord JJ. Expression of the endothelin-B receptor in pigment cell lesions of the skin. Evidence for its role as tumor progression marker in malignant melanoma. Virchows Arch 2001; 438:485-491.
23. Knowles J, Loizidou M, Taylor I. Endothelin-1 and angiogenesis in cancer. Curr Vasc Pharmacol 2006; 3:309-314.
24. Sullivan ME, Mumtaz FH, Khan MA, Dashwood MR, Thompson CS, Mikhailidis DP, Morgan RJ. Endothelins in the urinary tract. BJU Int 2000; 86:97-106.
25. Hansen-Schwartz J, Szok D, Edvinsson L. Expression of ET(A) and ET(B) receptor mRNA in human cerebral arteries. Br J Neurosurg 2002; 16:149-153.
26. Pedram A, Razandi M, Hu RM, Levin ER. Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion. J Biol Chem 1997; 272:17097-17103.
27. Shichiri M, Yokokura M, Marumo F, Hirata Y. Endothelin-1 inhibits apoptosis of vascular smooth muscle cells induced by nitric oxide and serum deprivation via MAP kinase pathway. Arterioscler Thromb Vasc Biol 2000; 20:989-997.
28. Sorokin A, Kohan DE. Physiology and pathology of endothelin-1 in renal mesangium. Am J Physiol Renal Physiol 2003; 285:F579-F589.
29. Kernochan LE, Tran BN, Tangkijvanich P, Melton AC, Tam SP, Yee HF. Endothelin-1 stimulates human colonic myofibroblast contraction and migration. Gut 2002; 50:65-70.
30. Ali H, Loizidou M, Dashwood M, Savage F, Sheard C, Taylor I. Stimulation of colorectal cancer cell line growth by ET-1 and its inhibition by ET(A) antagonists. Gut 2000; 47:685-688.
31. Carducci MA, Nelson JB, Saad FF, Schulman CC, Dearnaley DP, Sleep DJ, et al. Effects of atrasentan on disease progression and biological markers in men with metastatic hormone-refractory prostate cancer. Phase 3 study. In: Proceedings of the 40th American Society of Clinical Oncology Annual Meeting. New Orleans, USA, 2004.